As we look toward the future, we are excited to advance in our mission of defining what MR technology can become in the coming years. Yet, we also acknowledge the challenges that lie ahead of us in this journey.
It’s no secret that healthcare equity is a growing, pressing challenge. With an aging population worldwide, the disease burden is rising and increasing the need for MR procedures in an already stretched area of healthcare.
At ISMRM 2024 in Singapore, we launched our SIGNA™ Vision – an open invitation for you to join us in seeing the future of MR and help us change the outcome; and a commitment to continue to develop innovative MR technology that is accurate, accessible, and provides you with the actionable insights you need to address these growing challenges.
Today, we’re proud to both reaffirm this commitment and reflect on some of the milestones that take us one step closer to delivering on this vision.
As leaders in AI and digital solutions, we have continued to evolve our AI-enabled tools to help standardize clinical excellence and optimize efficiency over the past 12 months. At RSNA 2024 we announced the expansion of Sonic DL™ to 3D imaging*, a significant stride in delivering on our promise of Effortless Imaging.
In October 2024, we received FDA clearance for SIGNA MAGNUS‡, our premium, head-only MR scanner dedicated to brain exploration. This powerful device is designed to deliver the next neurological breakthroughs and pave the way for new treatments for some of the most debilitating and burdening diseases.
Our portfolio and innovations are built on the concept of broadening access to MR and pushing the boundaries of MR sustainability – both in an environmental and operational context. This exact concept has been the driving force behind Freelium‡‡ – our sealed magnet technology, unveiled at the European Congress of Radiology (ECR) in Vienna in February of this year.
Freelium is built upon our already proven and trusted lightweight magnet technology, and is designed to deliver a responsible, future-facing sealed magnet technology that prioritizes helium independence, operational security and energy efficiency alike.
As medtech pioneers, we’re always on a mission to push the boundaries of what MR can be. These recent milestones reflect GE HealthCare’s determination to stay on the edge of innovation, with a relentless focus on delivering medical technology that is effortless, sustainable and groundbreaking. I hope you will leave this year’s ISMRM inspired by the power to explore further and the accomplishments we should look forward to achieving together.
* Sonic DL for 3D is 510(k) pending at the US FDA. Not yet CE Marked. Not available for sale in all regions.
‡ SIGNA™ MAGNUS is 510(k) cleared with the FDA. Not yet CE Marked. Not available for sale in all regions.
‡‡ Technology in development that represents ongoing research and development efforts. Not for sale. Not CE marked. Not cleared or approved by the US FDA or any other global regulator for commercial availability.Do
Continue Reading
The power to explore further
Volume 38 — Spring 2025
Published
AI synergistically transforms the MR experience
Published
How we are fueling further exploration for clinicians and scientists
Published
GE HealthCare welcomes new SIGNA Sprint 1.5T to explore further
Published
In partnership with EU consortium, GE HealthCare to advance AI in healthcare through synthetic data
Published
PREDICTOM launches prospective study, gears up for MR protocol harmonization
Published
First modular MR in Southeast Asia
Published
ISMRM 2025 abstracts
Published
MR neurography imaging for all: providing a new service line using existing sequences and systems
Published
Progardia lowers energy consumption, reduces carbon footprint and increases image quality with continued investment in MR and AI
Published
Life-speed imaging with Sonic DL Cine opens up cardiac MR access to those who need it most
Published
Elevating neuro imaging with an upgrade to SIGNA PET/MR
By Ju-Chieh Kevin Cheng, PhD, UBC PET/MRI Physicist, Research Scientist at UBC Pacific Parkinson’s Research Centre, Vesna Sossi, PhD, Professor, Department of Physics and Astronomy, Adjunct Professor at Djavad Mowafaghian Centre for Brain Health, and Elham Shahinfard, PhD, PET-MR Imaging Program Manager, Charles E. Fipke Integrated Neuroimaging Suite, The University of British Columbia, Vancouver, British Columbia, Canada
Published
Advancing women’s imaging through collaboration
Published
The role of deep-learning T2 PROPELLER, diffusion and perfusion sequences in 3.0T MR evaluation of head-neck tumors
By Simona Marzi, PhD, medical physicist, Michele Farella, technologist, Giovanni Di Giulio, technologist, and Antonello Vidiri, MD, Medical Director, Regina Elena National Cancer Institute, Rome, Italy
Published
Leading the way in breast and pelvic imaging with SIGNA Hero
By Shunsuke Matsumoto, MD, Radiology Manager, Keiyu Hospital, Yokohama, Japan
Published
Shorter scan times and higher quality imaging reduce the need for sedation in pediatric patients
By Pär-Arne Svensson, BSc, Research Radiographer MRI, and Liz Ivarsson, MD, Senior Consultant and Pediatric Radiologist, Queen Silvia Children’s Hospital, Gothenburg, Sweden
Published
Enhancing surgical precision and patient outcomes with fMRI
By Yoshiyuki Watanabe, MD, PhD, Professor, Department of Radiology, Shiga University of Medical Science, Ōtsu, Shiga, Japan
Published
Bringing AIR Recon DL to multi-shot diffusion
By Patricia Lan, PhD, MR Scientist, Arnaud Guidon, PhD, Director of Body & Oncology MR, and Suryanarayanan “Shiv” Kauskik, PhD, Senior Digital Product Manager, GE HealthCare
Published
Ultra-high contrast MR of the brain and spinal cord
By Paul Condron, BSc (Hons), MRI Charge Technologist, Mark Bydder, PhD, Senior Research Fellow, Samantha J. Holdsworth, PhD, Executive Director at Mātai Medical Research Institute and Associate Professor at the University of Auckland, Daniel M. Cornfeld, MD, FRANZCR, Clinical Lead, and Graeme M. Bydder, FRANZCR, Scientific Advisory Board Member, Mātai Medical Research Institute, Gisborne, New Zealand
Published
Deuterium metabolic imaging shows promise in detecting Alzheimer’s disease
Published